Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (17)

2020

  1. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension

    FASEB Journal, Vol. 34, Núm. 10, pp. 13626-13640

2017

  1. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus

    Hypertension, Vol. 69, Núm. 4, pp. 641-650

  2. Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 312, Núm. 2, pp. H189-H200

2016

  1. Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction

    Biochemical Pharmacology, Vol. 110-111, pp. 25-36

2015

  1. Kv7 channels critically determine coronary artery reactivity: Left-right differences and down-regulation by hyperglycaemia

    Cardiovascular Research, Vol. 106, Núm. 1, pp. 98-108

2014

  1. The flavonoid quercetin induces acute vasodilator effects in healthy volunteers: Correlation with beta-glucuronidase activity

    Pharmacological Research, Vol. 89, pp. 11-18

  2. The flavonoid quercetin reverses pulmonary hypertension in rats

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension

    Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631

2012

  1. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741

  2. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension

    Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79

  3. Epicatechin: Endothelial function and blood pressure

    Journal of Agricultural and Food Chemistry

  4. Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation

    PLoS ONE, Vol. 7, Núm. 3

2011

  1. Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle

    British Journal of Nutrition, Vol. 105, Núm. 9, pp. 1287-1293

  2. Vascular deconjugation of quercetin glucuronide: The flavonoid paradox revealed?

    Molecular Nutrition and Food Research, Vol. 55, Núm. 12, pp. 1780-1790

2010

  1. Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation

    Atherosclerosis, Vol. 212, Núm. 1, pp. 78-85

2009

  1. Antihypertensive effects of the flavonoid quercetin

    Pharmacological Reports

2008

  1. Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability

    Planta Medica, Vol. 74, Núm. 7, pp. 741-746